Search - tctmd.com

Displaying 661 - 680 of 883

Sort: Relevancy | Date

Presentation TCT 2014

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

Presenter: Philippe Pibarot, Allan Schwartz, Gary Gershony, Josep Rodés-Cabau

September 16, 2014

Presentation TCT 2014

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Presenter: Thomas F. Luscher, Danny Dvir

September 16, 2014

Presentation TCT 2014

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

Presenter: William Wilson

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___

Presenter: Rhanderson Cardoso

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index

Presenter: Rajiv Tayal

September 16, 2014

Presentation TCT 2014

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Presenter: Ronald Binder

September 16, 2014

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

TCT 695: Clinical Impact and Evolution of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-analysis

Presenter: John A. Bittl, Tullio Palmerini, Luis Nombela-Franco, MD

September 15, 2014

Presentation TCT 2014

Case Presentation: An Unusual TAVI Procedure: Innovating in the Midst of a Difficult Scenario

Presenter: Alexandre Abizaid, Helio R Figueira, Jamil Abdalla Saad, Oscar A. Mendiz

September 13, 2014

Presentation TCT 2014

Case Presentation: My Worst TAVI Experience and What I Learned From It!

Presenter: Alexandre Abizaid, Helio R Figueira, Jamil Abdalla Saad, Magaly Arrais dos Santos

September 13, 2014

Presentation TCT 2014

Current Perspectives on TAVI Programs: Expanding Indications and Reducing Complications

Presenter: Alexandre Abizaid, Helio R Figueira, Jamil Abdalla Saad, Josep Rodés-Cabau

September 13, 2014

Presentation TCT 2014

Imaging Basics: Utilization of CT and Echo for Preprocedural and Periprocedural Decision Making

Presenter: Omar K. Khalique

September 13, 2014

Presentation TCT 2014

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Marco Barbanti

September 13, 2014

Presentation TCT 2014

TCT 691: Clinical Impact of the Presence of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation

Presenter: Valentin Fuster, Marina Urena, MD

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

Advertisement

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

TCT 695: Clinical Impact and Evolution of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-analysis

Case Presentation: An Unusual TAVI Procedure: Innovating in the Midst of a Difficult Scenario

Case Presentation: My Worst TAVI Experience and What I Learned From It!

Current Perspectives on TAVI Programs: Expanding Indications and Reducing Complications

Imaging Basics: Utilization of CT and Echo for Preprocedural and Periprocedural Decision Making

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

TCT 691: Clinical Impact of the Presence of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content